🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial tests the safety, side effects, and best dose of nivolum...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2022-11-03
Trial ID
NCT05272384
This phase II trial studies the effect of belinostat and SGI-110 (guadecita...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2020-09-08
Trial ID
NCT04340843
The purpose of this study is to constitute the French largest Aggressive fi...
Status
Active Not Recruiting
Location
Institut de Cancérologie de l'Ouest - Paul Papin
Start Date
2016-03-22
Trial ID
NCT02867033
To assess the effectiveness of a management strategy combining a broad pane...
Status
Completed
Location
Hôpital BICHAT
Start Date
2018-10-04
Trial ID
NCT03452826
Treatments Being Tested
This phase II trial tests how well a survivin peptide vaccine called SurVax...
Status
Not Yet Recruiting
Location
Rocky Mountain Regional VA Medical Center
Start Date
2026-10-01
Trial ID
NCT07169617
Systemic sclerosis (SSc) is the most severe of the systemic autoimmune dise...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-04
Trial ID
NCT04986514
Treatments Being Tested
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615
This research clinical trial is studying the creation and administration of...
Status
Terminated
Location
Boston Children's Hospital
Start Date
2020-01-29
Trial ID
NCT04239040
Treatments Being Tested
The GLUREDIA study investigates the counter-regulatory response (CRR) durin...
Status
Recruiting
Location
Clinique Universitaires Saint Luc
Start Date
2022-05-25
Trial ID
NCT06770621
This phase II/III trial studies how well daunorubicin and cytarabine with o...
Status
Active Not Recruiting
Location
University of Arkansas for Medical Sciences
Start Date
2019-03-28
Trial ID
NCT03701308